ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.62
0.96%
US Tech 100
18,064.80
0.02%
S&P 500
5,277.51
0.80%
US Dollar vs CAD
1.36525
0.00%
Bitcoin
67,627.57
-0.14%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Opko Health Inc (OPK)

  7. Opko Health Inc (OPK) News

OPK

Opko Health (OPK)

Opko Health Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OPK
DateTimeSourceHeadlineSymbolCompany
05/31/20249:48AMGlobeNewswire Inc.OPKO Health to Participate in the Jefferies Global Healthcare ConferenceNASDAQ:OPKOpko Health Inc
05/07/20243:29PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OPKOpko Health Inc
05/07/20243:07PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPKOpko Health Inc
05/07/20243:05PMGlobeNewswire Inc.OPKO Health Reports First Quarter 2024 Business Highlights and Financial ResultsNASDAQ:OPKOpko Health Inc
05/03/20247:00AMGlobeNewswire Inc.OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024NASDAQ:OPKOpko Health Inc
03/28/20247:00AMPR Newswire (US)Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics BusinessNASDAQ:OPKOpko Health Inc
03/20/20247:00AMGlobeNewswire Inc.Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatment for Patients with Short Bowel SyndromeNASDAQ:OPKOpko Health Inc
03/07/20243:02PMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:OPKOpko Health Inc
03/05/20247:52AMGlobeNewswire Inc.AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIVNASDAQ:OPKOpko Health Inc
03/01/20243:05PMEdgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405NASDAQ:OPKOpko Health Inc
02/28/20248:31AMPR Newswire (US)NextPlat Opens OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China on March 1stNASDAQ:OPKOpko Health Inc
02/27/20243:07PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPKOpko Health Inc
02/27/20243:05PMGlobeNewswire Inc.OPKO Health Reports Fourth Quarter 2023 Business Highlights and Financial ResultsNASDAQ:OPKOpko Health Inc
02/22/20243:05PMGlobeNewswire Inc.OPKO Health to Report Fourth Quarter 2023 Financial Results on February 27, 2024NASDAQ:OPKOpko Health Inc
02/16/20243:53PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:OPKOpko Health Inc
02/09/20243:07PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPKOpko Health Inc
02/05/20247:09AMPR Newswire (US)NextPlat Receives Initial Approvals to Launch OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in ChinaNASDAQ:OPKOpko Health Inc
01/29/20242:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPKOpko Health Inc
01/24/20243:15PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:OPKOpko Health Inc
01/24/20243:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPKOpko Health Inc
01/17/20244:09PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPKOpko Health Inc
01/10/20244:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPKOpko Health Inc
01/09/20244:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPKOpko Health Inc
01/09/20243:05PMGlobeNewswire Inc.OPKO Health Announces Closing of Private Offering of $230 Million Convertible Senior Notes Due 2029 including Full Exercise of Initial Purchaser’s Option to Purchase Additional NotesNASDAQ:OPKOpko Health Inc
01/08/20248:10AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPKOpko Health Inc
01/08/20247:00AMGlobeNewswire Inc.OPKO Health to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:OPKOpko Health Inc
01/05/20244:26PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPKOpko Health Inc
01/05/20243:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPKOpko Health Inc
01/05/202412:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPKOpko Health Inc
01/05/202411:42AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPKOpko Health Inc
 Showing the most relevant articles for your search:NASDAQ:OPK

Your Recent History

LSE
BC90
Citi Fun 25
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved